MARIE BLACKER: Open Payments
NPI 1326521543 · OREM, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$327 in 21 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $1,830 · 2025 $327
Food & beverage: $327
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $165 |
| Tris Pharma Inc | 3 | $62 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
| Neurocrine BioSciences, Inc. | 1 | $21 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
Products named: VRAYLAR, Dyanavel XR, TRINTELLIX, SPRAVATO, INGREZZA, Qelbree.
Industry payments across UT — which companies pay providers there.
